ALYSSA BEAN: Open Payments
NPI 1851888358 · GAINESVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,000 in 45 payments from 11 companies in 2025. Trend: 2023 $422 · 2024 $634 · 2025 $1,000
Food & beverage: $1,000
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $464 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $202 |
| Neurocrine BioSciences, Inc. | 4 | $92 |
| E.R. Squibb & Sons, L.L.C. | 3 | $69 |
| Alkermes, Inc. | 2 | $43 |
| Vanda Pharmaceuticals Inc. | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Luye Pharma (USA) Ltd. | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: VRAYLAR, CAPLYTA, INGREZZA, COBENFY, FANAPT, ARISTADA, TRINTELLIX, ERZOFRI EXTENDED-RELEASE.
Industry payments across FL — which companies pay providers there.
